20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
The private equity (PE) playbook is evolving. Rapid buy-and-sell cycles are giving way to continuation vehicles and longer hold periods, demanding a new approach to…
Read more
The private equity landscape continues to evolve, influenced by macroeconomic shifts and emerging trends. The ecosystem is becoming increasingly polarized, with firms gravitating towards either…
Read more
Why is it that most mergers, reorganizations, and downsizings fail to generate their anticipated full value? The main reason is that a lack of effective…
Read more
Erhalten Sie jeden Monat Neuigkeiten und wertvolle Perspektiven zu Themen der organisatorischen Effektivität
